Table 1. Clinicobiologic and pathologic characteristics of involved patients.
| Variable | Overall cohort | GS=6 Cohort |
|---|---|---|
| Age, Mean (SD), yr: | 67.12 (7.24) | 66.06 (7.25) |
| BMI, Mean (SD) | 24.07 (2.78) | 23.84 (2.95) |
| BMI≥24 | 215 (52.31) | 75 (49.02) |
| BMI≥28 | 26 (6.33) | 10 (6.54) |
| PSA, Median (IQR), ng/ml | 10.84 (12.85) | 9.7 (9.16) |
| PV, Median (IQR), ml: | 32.76 (22.23) | 36.4 (27.04) |
| PSAD, Median (IQR), ng/ml per gram | 0.33 (0.44) | 0.29 (0.33) |
| clinical stage | ||
| t1c | 80 (19.46) | 37 (24.18) |
| t2a | 65 (15.82) | 25 (16.34) |
| t2b | 166 (40.39) | 67 (43.79) |
| t2c | 67 (16.30) | 21 (13.73) |
| t3 | 22 (5.35) | 1 (0.65) |
| t4 | 11 (2.68) | 2 (1.31) |
| Biopsy specimens features: | ||
| Biopsy cores, Median (IQR) | 12 (1.00) | 12 (2.00) |
| Postive cores, Median (IQR) | 4 (4.00) | 2 (3.00) |
| % of positive cores, Median (IQR), % | 31 (33.33) | 20 (23.33) |
| Biopsy gleason score, No (%) | ||
| 6 | 153 (37.23) | 153 (100) |
| 3+4 | 84 (20.44) | - |
| 4+3 | 52 (12.65) | - |
| 8 | 70 (17.03) | - |
| 9 | 41 (9.98) | - |
| 10 | 11 (2.68) | - |
| RP specimens features: | ||
| RP Gleason score, No (%) | ||
| 6 | 81 (19.71) | 61 (39.87) |
| 3+4 | 158 (38.44) | 65 (42.48) |
| 4+3 | 60 (14.60) | 17 (11.11) |
| 8 | 51 (12.41) | 6 (3.92) |
| 9 | 55 (13.38) | 4 (2.61) |
| 10 | 6 (1.46) | - |
| PSM, No (%) | 103 (25.06) | 27 (17.65) |
| SVI, No (%) | 48 (11.68) | 4 (2.61) |
| EMI, No (%) | 89 (21.65) | 19 (12.42) |
| LMP, No (%) | 11 (2.68) | - |
| Nerve, No (%) | 117 (28.47) | 25 (16.34) |
PV=prostate volume; PSM=positive surgerical margin; SVI=seminal vesicle invasion; EMI=extraprostic invasion; LMP=lymph node positive;